Search

1. Crizanlizumab, voxelotor, and L-glutamine for sickle cell disease: effectiveness and value

Author(s):

Bradt, Pamela, author
Synnott, Patricia G., author
Chapman, Rick M., author
Beinfeld, Molly, author
Rind, David M., author
Pearson, Steven D., author

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, March 12, 2020

Subject(s):

Anemia, Sickle Cell -- drug therapy
Antibodies, Monoclonal -- therapeutic use
Glutamine -- therapeutic use
Hemoglobin, Sickle -- antagonists & inhibitors
United States

2. Aducanumab for Alzheimer’s disease: effectiveness and value : final evidence report and meeting summary

Author(s):

Lin, Grace A., author
Whittington, Melanie D., author
Synnott, Patricia G., author
McKenna, Avery, author
Campbell, Jon, author
Pearson, Steven D., author
Rind, David M., author

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, August 5, 2021

Subject(s):

Alzheimer Disease -- drug therapy
Antibodies, Monoclonal
United States

3. Betibeglogene autotemcel for beta thalassemia: effectiveness and value : final evidence report

Author(s):

Beaudoin, Francesca L., author
Richardson, Marina, author
Synnott, Patricia G., author
Lancaster, Victoria, author
Fluetsch, Noemi, author
Herce-Hagiwara, Belén, author
Campbell, Jon D., author
Pearson, Steven D., author
Rind, David M., author

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, July 19, 2022

Subject(s):

beta-Thalassemia -- therapy
Biological Products -- therapeutic use
Genetic Therapy
United States